The role of beta-blocking agents in perioperative medicine. Part 2: Therapeutic indications;Interet des beta-bloquants en medecine perioperatoire. Deuxieme partie: Indications therapeutiques

Canadian Journal of Anaesthesia

Volumn 47, Issue 7, 2000, Pages 664-672

  Piriou, V ^a   Aouifi, A ^a   Lehot, J J ^a  

^a LOUIS PRADEL HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ACUTE HEART INFARCTION; ARTICLE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; CORONARY ARTERY SURGERY; DRUG EFFICACY; DRUG USE; HEART FAILURE; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; HYPOTENSION; MEDICAL INFORMATION; PERIOPERATIVE PERIOD; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; RISK FACTOR; CARDIOVASCULAR DISEASE; HEART INFARCTION; REVIEW;

ADRENERGIC BETA-ANTAGONISTS; CARDIOVASCULAR DISEASES; CORONARY DISEASE; HUMANS; HYPERTENSION; MYOCARDIAL INFARCTION; PERIOPERATIVE CARE;

EID: 0034220639     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03019000     Document Type: Article

References (79)

1. Hemodynamic effects of anesthesia and surgery in renal hypertensive patients receiving large doses of beta-receptor antagonists
2. Myocardial ischemia in untreated hypertensive patients: Effect of a single small oral dose of a beta-adrenergic blocking agent
3. Beta blockade to decrease silent myocardial ischemia during peripheral vascular surgery
4. The hemodynamics of beta-blockade in patients undergoing abdominal aortic aneurysm repair
5. The effect of bisoprolol on perioperative mortality and myocardial infartion in high-risk patients undergoing vascular surgery
6. Outcome studies in perioperative medicine: The β-blockade trials
7. Prophylactic atenolol reduces postoperative myocardial ischemia
8. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery
9. Cerebral blood flow during anaesthesia: Influence of pretreatment with metoprolol or captopril
10. Long-term metoprolol therapy and neuroleptanesthesia in coronary artery surgery: Withdrawal versus maintenance of beta 1-adrenoreceptor blockade
11. Coronary artery syndromes after sudden propranolol withdrawal
12. Withdrawal of propranolol and myocardial infarction (Letter)
13. Part I. Guidelines for assessing and managing the perioperative risk from coronary artery disease associated with major noncardiac surgery
14. Interferences medicamenteuses
15. Heart rate and blood pressure effects of esmolol after ketamine induction and intubation
16. Esmolol for control of increases in heart rate and blood pressure during tracheal intubation after thiopentone and succinylcholine
17. Evaluation of esmolol in controlling increases in heart rate and blood pressure during endotracheal intubation in patients undergoing carotic endarterectomy
18. Use of esmolol during anesthesia to treat tachycardia and hypertension
19. 2 pneumoperitoneum for laparoscopic surgery
20. Propranolol postoperative maintenance by continuous intravenous infusion
21. Continuous i.v. infusion of labetolol for postoperative hypertension. Haemodynamic effects and plasma kinetics
22. Prolonged continuous infusion labetolol: A new alternative for parenteral antihypertensive therapy
23. Labetalol to control blood pressure after cardiovascular surgery
24. Postcardiac surgical hypertension
25. Beta-adrenergic blockade accelerates conversion of postoperative supraventricular tachyarrhythmias
26. The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery
27. Does perioperative myocardial ischemia lead to postoperative myocardial infarction?
28. Anesthesies des pontages aorto-coronaires
29. Calcium channel blockade does not offer adequate protection from perioperative myocardial ischemia
30. MB creatine kinase and the evaluation of myocardial injury following aortocoronary bypass operation
31. Effect of intraoperative propranolol on serum creatine kinase MB release in patients having elective cardiac operations
32. Prevention of supraventricular tachyarrhythmias after open heart operation by low-dose sotalol: A prospective, double-blind, randomized, placebo-controlled study
33. Comparison of perioperative myocardial protection with nifedipine versus nifedipine and metoprolol in patients undergoing elective coronary artery bypass grafting
34. Does chronic treatment with calcium entry blocking drugs reduce perioperative myocardial ischemia?
35. Life-threatening complications of cardiac operations and occurrence of myocardial catecholamine bombs
36. The effects of beta-adrenoreceptor blockade on oxygen consumption during cardiopulmonary bypass
37. When asleep, one is cooler on beta-blockade than on placebo: A study of pulmonary arterial blood temperature and skeletal muscle heat production in anaesthetized man
38. Drug therapy before coronary artery surgery: Nitrates are independent predictors of mortality and beta-adrenergic blockers predict survival
39. Beta-blockade and neurological outcome in cardiac surgery
40. Plasma propranolol before, during, and after cardiopulmonary bypass
41. Acebutol and diacetolol plasma levels in patients undergoing myocardial revascularization with hypothermic cardiopulmonary bypass
42. Perioperative variability of binding of lidocaine, quinidine, and propranolol after cardiac operations
43. The efficacy of amrinone or adrenaline on low cardiac output following cardiopulmonary bypass in patients with coronary artery disease undergoing preoperative beta-blockade
44. Combined alpha- and beta-blockade with labetalol in post-open heart surgery hypertension. Reversal of hemodynamic deterioration with glucagon
45. Hemodynamic and adrenergic responses to anesthesia and operation for myocardial revascularisaiton
46. Propranolol-induced postoperative hypertension following coronary artery bypass grafting
47. Factors relating to the development of hypertension after cardiopulmonary bypass
48. Haemodynamic effects of celiprotol and sotalol after coronary artery bypass grafting
49. Efficacy and safety of low-dose propranolol versus diltiazem in the prophylaxis of supraventricular tachyarrhythmia after coronary artery bypass grafting
50. Comparison of sotalol and metoprolol in the prevention of atrial fibrillation after coronary artery bypass surgery
51. Influence of beta 1-blockade on myocardial substrates early after a coronary operation
52. Heart block after coronary artery bypass - Effect of chronic administration of calcium-entry blockers and beta-blockers
53. Esmolol: Safety and efficacy in postoperative cardiothoracic patients with supraventricular tachyarrhythmias
54. Hemodynamic effects of esmolol in chronically beta-blocked patients undergoing aortocoronary bypass surgery
55. The effect of esmolol given during cardiopulmonary bypass
56. Effects of high-dose esmolol on oxygen delivery and oxygen uptake in patients undergoing minimally invasive coronary artery surgery
57. Myocardial metabolism and hemodynamics during coronary surgery without cardiopulmonary bypass
58. Labetalol in controlled hypotension. Administration of labetalol when adequate hypotension is difficult to achieve
59. Cardiovascular effects of labetalol during halothane anaesthesia
60. Intravenous labetalol for induced hypotension in an adult patient undergoing coarctation repair
61. Impact of propranolol on hemodynamic response and blood cyanide levels during nitroprusside infusion: A prospective study in anesthetized man
62. Acute beta-adrenoreceptor blockade and induced hypotension
63. Propranolol prevents hemodynamic and humoral events after abrupt withdrawal of nitroprusside
64. Dupont critical care lecture: Role of ultra-short acting beta-blockers in the perioperative period
65. Endocrine disease
66. Continuous intravenous infusions of phentolamine and esmolol for preoperative and intra-operative blockade in patients with pheochomocytoma
67. Use of esmolol in the intraoperative management of pheochromocytoma
68. Metoprolol in the treatment of multifocal atrial tachycardia
69. Limitation of infarct size in man by the beta-1-blocker metoprolol
70. Limitation of myocardial infarct size in patients less than 66 years treated with a prenolol
71. Reduction of enzyme level by propranolol after acute myocardial infarction
72. Effect of propranolol on myocardial infarct size in a randomized blinded multicenter trial
73. Early intravenous atenolol treatment in suspected acute myocardial infarction. Preliminary report of a randomized trial
74. The safety of combined thrombolysis and beta-adrenergic blockade in patients with acute myocardial infarction. A randomized study
75. Costs and effectiveness of routine therapy with long-term beta-adrenergic antagonists after acute myocardial infarction
76. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction
77. Clinical effects of beta-adrenergic blockade in chronic heart failure. A meta-analysis of double-blind, placebo-controlled, randomized trials
78. Beta-bloquants et hemorragies digestives
79. Reduction of stress catecholamine-induced cardiac necrosis by beta 1-selective blockade